Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001326732-25-000037
Filing Date
2025-03-13
Accepted
2025-03-13 16:42:35
Documents
15
Period of Report
2025-02-27
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A xncr-20250227.htm   iXBRL 8-K/A 32656
2 EX-16.1 xncr-20250227xexx161.htm EX-16.1 1031
6 xncr-20250227xexx161001.jpg GRAPHIC 62580
  Complete submission text file 0001326732-25-000037.txt   245272

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xncr-20250227.xsd EX-101.SCH 1779
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xncr-20250227_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xncr-20250227_pre.xml EX-101.PRE 12506
17 EXTRACTED XBRL INSTANCE DOCUMENT xncr-20250227_htm.xml XML 2730
Mailing Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107
Business Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107 626-305-5900
Xencor Inc (Filer) CIK: 0001326732 (see all company filings)

EIN.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36182 | Film No.: 25736468
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)